Evidence for tumor-host cooperation in regulating MMP-2 expression in human colon cancer

被引:31
作者
Ornstein, DL
MacNab, J
Cohn, KH
机构
[1] VA Med & Reg Off Ctr, White River Junction, VT 05009 USA
[2] Dartmouth Coll, Sch Med, Dept Med & Surg, Hanover, NH 03755 USA
关键词
colon cancer; fibroblast; metalloproteinase; metastasis;
D O I
10.1023/A:1006562818088
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Matrix metalloproteinase 2 (MMP-2) facilitates tumor growth and metastasis in colon cancer. Although tumor cells may produce MMP-2, stromal cells, such as macrophages and fibroblasts, contribute significantly to MMP-2 synthesis in human tumors. We characterized four human colon cancer cell lines with differing biological behavior for MMP-2 expression. While the parent tumors from which the cell lines were derived all expressed MMP-2 mRNA, MMP-2 transcripts were detected in only one cell line, TF-17C, which is nontumorigenic in a nude mouse tumor model. TF-43C, which is tumorigenic and metastatic in the same tumor model, did not produce MMP-2, yet the tumors which arose from it after injection into nude mice did contain MMP-2 mRNA, suggesting a contribution from stromal cells. Co-culturing TF-43C with fibroblasts resulted in an increase in MMP-2 protein, whereas co-culturing with the nontumorigenic cell line TF-13Cm did not alter constitutive fibroblast MMP-2 secretion. Conditioned medium from TF-43C cells also stimulated fibroblast MMP-2 production. These data suggest that a soluble factor from TF-43C cells can stimulate fibroblast MMP-2 production and support the hypothesis that colon cancer cell interactions with stromal fibroblasts may be important determinants of tumor behavior in vivo.
引用
收藏
页码:205 / 212
页数:8
相关论文
共 52 条
[1]   Conversion of highly malignant colon cancer from an aggressive to a controlled disease by oral administration of a metalloproteinase inhibitor [J].
An, ZL ;
Wang, XE ;
Willmott, N ;
Chander, SK ;
Tickle, S ;
Docherty, AJP ;
Mountain, A ;
Millican, AT ;
Morphy, R ;
Porter, JR ;
Epemolu, RO ;
Kubota, T ;
Moossa, AR ;
Hoffman, RM .
CLINICAL & EXPERIMENTAL METASTASIS, 1997, 15 (02) :184-195
[2]  
BARSKY SH, 1983, LAB INVEST, V49, P140
[3]   PROTEOLYTIC REMODELING OF EXTRACELLULAR-MATRIX [J].
BIRKEDALHANSEN, H .
CURRENT OPINION IN CELL BIOLOGY, 1995, 7 (05) :728-735
[4]   Changing views of the role of matrix metalloproteinases in metastasis [J].
Chambers, AF ;
Matrisian, LM .
JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1997, 89 (17) :1260-1270
[5]   The differential regulation and secretion of proteinases from fetal and neonatal fibroblasts by growth factors [J].
Cullen, B ;
Silcock, D ;
Brown, LJ ;
Gosiewska, A ;
Geesin, JC .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 1997, 29 (01) :241-250
[6]  
DANEKER GW, 1987, ARCH SURG-CHICAGO, V122, P1470
[7]   Matrix metalloproteinase inhibitors: Present achievements and future prospects [J].
Denis, LJ ;
Verweij, J .
INVESTIGATIONAL NEW DRUGS, 1997, 15 (03) :175-185
[8]  
EMMERTBUCK MR, 1994, AM J PATHOL, V145, P1285
[9]  
FARRELL TM, 1998, IN PRESS GASTROENTER
[10]   TUMOR BASEMENT-MEMBRANE LAMININ IN ADENOCARCINOMA OF RECTUM - AN IMMUNOHISTOCHEMICAL STUDY OF BIOLOGICAL AND CLINICAL-SIGNIFICANCE [J].
FORSTER, SJ ;
TALBOT, IC ;
CLAYTON, DG ;
CRITCHLEY, DR .
INTERNATIONAL JOURNAL OF CANCER, 1986, 37 (06) :813-817